CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression | |
Ji, Ming; Wang, Liyuan; Chen, Ju; Xue, Nina; Wang, Chunyang; Lai, Fangfang; Wang, Rubing; Yu, Shishan; Jin, Jing; Chen, Xiaoguang | |
2018 | |
卷号 | 11页码:3671-3684 |
关键词 | Gli inhibitor chemotherapy lomeguatrib xenograft tumor model |
ISSN号 | 1178-6930 |
DOI | 10.2147/OTT.S163535 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6357666 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Ji, Ming,Wang, Liyuan,Chen, Ju,et al. CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression[J],2018,11:3671-3684. |
APA | Ji, Ming.,Wang, Liyuan.,Chen, Ju.,Xue, Nina.,Wang, Chunyang.,...&Chen, Xiaoguang.(2018).CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression.,11,3671-3684. |
MLA | Ji, Ming,et al."CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression".11(2018):3671-3684. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论